Analyze Diet
Animals : an open access journal from MDPI2023; 13(8); doi: 10.3390/ani13081367

Changes in Calprotectin (S100A8-A9) and Aldolase in the Saliva of Horses with Equine Gastric Ulcer Syndrome.

Abstract: Equine gastric ulcer syndrome (EGUS) is a highly prevalent disease that affects horses worldwide. Within EGUS, two different forms have been described: equine squamous gastric disease (ESGD) and equine glandular gastric disease (EGGD). The associated clinical signs cause detrimental activity performance, reducing the quality of life of animals. Saliva can contain biomarkers for EGUS that could be potentially used as a complementary tool for diagnosis. The objective of this work was to evaluate the measurements of calprotectin (CALP) and aldolase in the saliva of horses as potential biomarkers of EGUS. For this purpose, automated assays for the quantification of these two proteins were analytically validated and applied for detecting EGUS in a total of 131 horses divided into 5 groups: healthy horses, ESGD, EGGD, combined ESGD and EGGD, and horses with other intestinal pathologies. The assays showed good precision and accuracy in analytical validation, and they were able to discriminate between horses with EGUS and healthy horses, especially in the case of CALP, although they did not show significant differences between horses with EGUS and horses with other diseases. In conclusion, salivary CALP and aldolase can be determined in the saliva of horses and further studies are warranted to elucidate the potential of these analytes as biomarkers in EGUS.
Publication Date: 2023-04-16 PubMed ID: 37106929PubMed Central: PMC10135270DOI: 10.3390/ani13081367Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

This research paper explores the possibility of using salivary levels of two proteins, calprotectin (CALP) and aldolase, as indicative markers for equine gastric ulcer syndrome (EGUS), a common disease in horses. The study found that measuring these biomarkers could help to distinguish between healthy horses and those affected by EGUS, particularly using CALP, but further research is required to confirm their potential role in diagnosing this condition.

Understanding the Research

  • The study focuses on Equine Gastric Ulcer Syndrome (EGUS), a widespread disease affecting horses globally. The illness comes in two forms, equine squamous gastric disease (ESGD) and equine glandular gastric disease (EGGD). Its symptoms can severely impact an animal’s performance and degrade its life quality.
  • The researchers hypothesized that the saliva of horses could hold biomarkers for EGUS that might aid or supplement traditional diagnostic methods. They decided to evaluate two specific proteins found in saliva, known as calprotectin (CALP) and aldolase, for their potential as EGUS biomarkers.

Methodology and Results

  • Automated assays were used to quantify the levels of CALP and aldolase in the saliva of a total of 131 horses. These animals were categorized into five groups: healthy horses, those with ESGD, those with EGGD, those with both ESGD and EGGD, and horses with other intestinal diseases.
  • The assays demonstrated good accuracy and precision in their analytical validation process. They managed to distinguish between healthy horses and those with EGUS, with calprotectin proving particularly useful in making this distinction.
  • However, the assays didn’t show significant differences between horses with EGUS and those with other types of intestinal diseases. This suggests more specific or sensitive biomarkers might be needed to accurately diagnose EGUS.

Conclusions

  • The study concludes that it is possible to measure the salivary levels of CALP and aldolase in horses, and these proteins might serve as potential EGUS biomarkers.
  • However, further studies are needed to fully understand the potential of these two proteins as diagnostic tools for EGUS. Particularly, more research is required to differentiate between EGUS and other digestive system diseases in horses.

Cite This Article

APA
Muñoz-Prieto A, Contreras-Aguilar MD, Cerón JJ, Ayala de la Peña I, Martín-Cuervo M, Eckersall PD, Holm Henriksen IM, Tecles F, Hansen S. (2023). Changes in Calprotectin (S100A8-A9) and Aldolase in the Saliva of Horses with Equine Gastric Ulcer Syndrome. Animals (Basel), 13(8). https://doi.org/10.3390/ani13081367

Publication

ISSN: 2076-2615
NlmUniqueID: 101635614
Country: Switzerland
Language: English
Volume: 13
Issue: 8

Researcher Affiliations

Muñoz-Prieto, Alberto
  • Interdisciplinary Laboratory of Clinical Analysis (INTERLAB-UMU), Department of Animal Medicine and Surgery, Veterinary School, Regional Campus of International Excellence Mare Nostrum, University of Murcia, 30100 Murcia, Spain.
Contreras-Aguilar, María Dolores
  • Interdisciplinary Laboratory of Clinical Analysis (INTERLAB-UMU), Department of Animal Medicine and Surgery, Veterinary School, Regional Campus of International Excellence Mare Nostrum, University of Murcia, 30100 Murcia, Spain.
Cerón, José Joaquín
  • Interdisciplinary Laboratory of Clinical Analysis (INTERLAB-UMU), Department of Animal Medicine and Surgery, Veterinary School, Regional Campus of International Excellence Mare Nostrum, University of Murcia, 30100 Murcia, Spain.
Ayala de la Peña, Ignacio
  • Interdisciplinary Laboratory of Clinical Analysis (INTERLAB-UMU), Department of Animal Medicine and Surgery, Veterinary School, Regional Campus of International Excellence Mare Nostrum, University of Murcia, 30100 Murcia, Spain.
Martín-Cuervo, María
  • Animal Medicine, Faculty of Veterinary Medicine of Cáceres, University of Extremadura, Av. de la Universidad S-N, 10005 Cáceres, Spain.
Eckersall, Peter David
  • Interdisciplinary Laboratory of Clinical Analysis (INTERLAB-UMU), Department of Animal Medicine and Surgery, Veterinary School, Regional Campus of International Excellence Mare Nostrum, University of Murcia, 30100 Murcia, Spain.
  • School of Biodiversity, One Health and Veterinary Medicine, University of Glasgow, Bearsden Rd, Glasgow G61 1QH, UK.
Holm Henriksen, Ida-Marie
  • Department of Veterinary Clinical Sciences, Veterinary School of Medicine, Sektion Medicine and Surgery, University of Copenhagen, Hoejbakkegaard Allé 5, DK-2630 Høje-Taastrup, Denmark.
Tecles, Fernando
  • Interdisciplinary Laboratory of Clinical Analysis (INTERLAB-UMU), Department of Animal Medicine and Surgery, Veterinary School, Regional Campus of International Excellence Mare Nostrum, University of Murcia, 30100 Murcia, Spain.
Hansen, Sanni
  • Animal Medicine, Faculty of Veterinary Medicine of Cáceres, University of Extremadura, Av. de la Universidad S-N, 10005 Cáceres, Spain.

Grant Funding

  • 19894/GERM/15 / Fundación Séneca - Agencia de Ciencia y Tecnología de la Región de Murcia
  • RYC2021-033660-I / Ministerio de Ciencia e Innovación, Agencia Estatal de Investigación

Conflict of Interest Statement

The authors declare no conflict of interest.

References

This article includes 34 references
  1. Van den Boom R. Equine Gastric Ulcer Syndrome in Adult Horses. Vet. J. 2022;283–284:105830.
    doi: 10.1016/j.tvjl.2022.105830pubmed: 35472513google scholar: lookup
  2. Merritt A.M.. Appeal for Proper Usage of the Term ‘EGUS’: Equine Gastric Ulcer Syndrome. Equine Vet. J. 2009;41:616.
    doi: 10.2746/042516409X454574pubmed: 19927576google scholar: lookup
  3. Sykes B.W., Hewetson M., Hepburn R.J., Luthersson N., Tamzali Y. European College of Equine Internal Medicine Consensus Statement-Equine Gastric Ulcer Syndrome in Adult Horses. J. Vet. Intern. Med. 2015;29:1288–1299.
    doi: 10.1111/jvim.13578pmc: PMC4858038pubmed: 26340142google scholar: lookup
  4. Camacho-Luna P., Buchanan B., Andrews F.M.. Advances in Diagnostics and Treatments in Horses and Foals with Gastric and Duodenal Ulcers. Vet. Clin. N. Am. Equine Pract. 2018;34:97–111.
    doi: 10.1016/j.cveq.2017.11.007pubmed: 29534810google scholar: lookup
  5. Niedźwiedź A., Kubiak K., Nicpoń J. Endoscopic Findings of the Stomach in Pleasure Horses in Poland. Acta Vet. Scand. 2013;55:45.
    doi: 10.1186/1751-0147-55-45pmc: PMC3680328pubmed: 24044656google scholar: lookup
  6. Muñoz-Prieto A., Cerón J.J., Rubio C.P., Contreras-Aguilar M.D., Pardo-Marín L., Ayala-de la Peña I., Martín-Cuervo M., Holm Henriksen I.-M., Arense-Gonzalo J.J., Tecles F.. Evaluation of a Comprehensive Profile of Salivary Analytes for the Diagnosis of the Equine Gastric Ulcer Syndrome. Animals 2022;12:3261.
    doi: 10.3390/ani12233261pmc: PMC9740180pubmed: 36496782google scholar: lookup
  7. Contreras-Aguilar M.D., Rubio C.P., González-Arostegui L.G., Martín-Cuervo M., Cerón J.J., Ayala I., Henriksen I.M.H., Jacobsen S., Hansen S. Changes in Oxidative Status Biomarkers in Saliva and Serum in the Equine Gastric Ulcer Syndrome and Colic of Intestinal Aetiology: A Pilot Study. Animals 2022;12:667.
    doi: 10.3390/ani12050667pmc: PMC8909870pubmed: 35268236google scholar: lookup
  8. Cerón J.J., Contreras-Aguilar M.D., Escribano D., Martínez-Miró S., López-Martínez M.J., Ortín-Bustillo A., Franco-Martínez L., Rubio C.P., Muñoz-Prieto A., Tvarijonaviciute A.. Basics for the Potential Use of Saliva to Evaluate Stress, Inflammation, Immune System, and Redox Homeostasis in Pigs. BMC Vet. Res. 2022;18:81.
    doi: 10.1186/s12917-022-03176-wpmc: PMC8883734pubmed: 35227252google scholar: lookup
  9. Muñoz-Prieto A., Escribano D., Contreras-Aguilar M.D., Horvatić A., Guillemin N., Jacobsen S., Cerón J.J., Mrljak V. Tandem Mass Tag (TMT) Proteomic Analysis of Saliva in Horses with Acute Abdominal Disease. Animals 2021;11:1304.
    doi: 10.3390/ani11051304pmc: PMC8147179pubmed: 33946607google scholar: lookup
  10. Jukic A., Bakiri L., Wagner E.F., Tilg H., Adolph T.E.. Calprotectin: From Biomarker to Biological Function. Gut 2021;70:1978–1988.
    doi: 10.1136/gutjnl-2021-324855pmc: PMC8458070pubmed: 34145045google scholar: lookup
  11. Manz M., Burri E., Rothen C., Tchanguizi N., Niederberger C., Rossi L., Beglinger C., Lehmann F.S.. Value of Fecal Calprotectin in the Evaluation of Patients with Abdominal Discomfort: An Observational Study. BMC Gastroenterol. 2012;12:5.
    doi: 10.1186/1471-230X-12-5pmc: PMC3267677pubmed: 22233279google scholar: lookup
  12. Kim J.W., Jung J.Y., Lee S.W., Baek W.Y., Kim H.A., Suh C.H.. S100A8 in Serum, Urine, and Saliva as a Potential Biomarker for Systemic Lupus Erythematosus. Front. Immunol. 2022;13:886209.
    doi: 10.3389/fimmu.2022.886209pmc: PMC9073082pubmed: 35529863google scholar: lookup
  13. Ananda Rao G., Abraham S. Triglyceride Synthesis from Dihydroxyacetone Phosphate and Palmitate by Microsomes from Mammary Glands of Lactating Mice. Lipids 1978;13:95–98.
    doi: 10.1007/BF02533374pubmed: 628319google scholar: lookup
  14. Yamamoto T., Kudo M., Peng W.X., Takata H., Takakura H., Teduka K., Fujii T., Mitamura K., Taga A., Uchida E.. Identification of Aldolase A as a Potential Diagnostic Biomarker for Colorectal Cancer Based on Proteomic Analysis Using Formalin-Fixed Paraffin-Embedded Tissue. Tumor Biol. 2016;37:13595–13606.
    doi: 10.1007/s13277-016-5275-8pmc: PMC5097088pubmed: 27468721google scholar: lookup
  15. Faleiros R.R., Nuovo G.J., Belknap J.K.. Calprotectin in Myeloid and Epithelial Cells of Laminae from Horses with Black Walnut Extract-Induced Laminitis. J. Vet. Intern. Med. 2009;23:174–181.
  16. Grosche A., Morton A.J., Polyak M.M.R., Matyjaszek S., Freeman D.E.. Detection of Calprotectin and Its Correlation to the Accumulation of Neutrophils within Equine Large Colon during Ischaemia and Reperfusion. Equine Vet. J. 2008;40:393–399.
    doi: 10.2746/042516408X302500pubmed: 18487110google scholar: lookup
  17. Garnett E., Pagaduan J., Rajapakshe D., Tam E., Kellermayer R., Devaraj S.. Validation of the Newly FDA-Approved Buhlmann FCal Turbo Assay for Measurement of Fecal Calprotectin in a Pediatric Population. Pract. Lab. Med. 2020;22:e00178.
    doi: 10.1016/j.plabm.2020.e00178pmc: PMC7585138pubmed: 33134465google scholar: lookup
  18. López-Martínez M.J., Cerón J.J., Ortín-Bustillo A., Escribano D., Kuleš J., Beletić A., Rubic I., González-Sánchez J.C., Mrljak V., Martínez-Subiela S.. A Proteomic Approach to Elucidate the Changes in Saliva and Serum Proteins of Pigs with Septic and Non-Septic Inflammation. Int. J. Mol. Sci. 2022;23:6738.
    doi: 10.3390/ijms23126738pmc: PMC9223627pubmed: 35743177google scholar: lookup
  19. Henneke D.R., Potter G.D., Kreider J.L., Yeates B.F.. Relationship between Condition Score, Physical Measurements and Body Fat Percentage in Mares. Equine Vet. J. 1983;15:371–372.
  20. Contreras-Aguilar M.D., Hevia M.L., Escribano D., Lamy E., Tecles F., Cerón J.J.. Effect of Food Contamination and Collection Material in the Measurement of Biomarkers in Saliva of Horses. Res. Vet. Sci. 2020;129:90–95.
    doi: 10.1016/j.rvsc.2020.01.006pubmed: 31954319google scholar: lookup
  21. Perkins N.J., Schisterman E.F.. The Inconsistency of “Optimal” Cutpoints Obtained Using Two Criteria Based on the Receiver Operating Characteristic Curve. Am. J. Epidemiol. 2006;163:670–675.
    doi: 10.1093/aje/kwj063pmc: PMC1444894pubmed: 16410346google scholar: lookup
  22. Altschul S.. Gapped BLAST and PSI-BLAST: A New Generation of Protein Database Search Programs. Nucleic Acids Res. 1997;25:3389–3402.
    doi: 10.1093/nar/25.17.3389pmc: PMC146917pubmed: 9254694google scholar: lookup
  23. Banse H.E., Andrews F.M.. Equine Glandular Gastric Disease: Prevalence, Impact and Management Strategies. Vet. Med. Res. Rep. 2019;10:69–76.
    doi: 10.2147/VMRR.S174427pmc: PMC6642651pubmed: 31406687google scholar: lookup
  24. Muñoz-Prieto A., Contreras-Aguilar M.D., Cerón J.J., Ayala I., Martin-Cuervo M., Gonzalez-Sanchez J.C., Jacobsen S., Kuleš J., Beletić A., Rubic I.. Changes in Proteins in Saliva and Serum in Equine Gastric Ulcer Syndrome Using a Proteomic Approach. Animals 2022;12:1169.
    doi: 10.3390/ani12091169pmc: PMC9103582pubmed: 35565595google scholar: lookup
  25. Ryckman C., Vandal K., Rouleau P., Talbot M., Tessier P.A.. Proinflammatory Activities of S100: Proteins S100A8, S100A9, and S100A8/A9 Induce Neutrophil Chemotaxis and Adhesion. J. Immunol. 2003;170:3233–3242.
    doi: 10.4049/jimmunol.170.6.3233pubmed: 12626582google scholar: lookup
  26. Leach S.T., Mitchell H.M., Geczy C.L., Sherman P.M., Day A.S.. S100 Calgranulin Proteins S100A8, S100A9 and S100A12 Are Expressed in the Inflamed Gastric Mucosa of Helicobacter Pylori -Infected Children. Can. J. Gastroenterol. 2008;22:461–464.
    doi: 10.1155/2008/308942pmc: PMC2660800pubmed: 18478131google scholar: lookup
  27. Huang J.A., Huang H.D., Peng Q.B., Zhu Z.J., Yu X.R.. S100 Protein-Positive Dendritic Cells and the Significance of Their Density in Gastric Precancerous Lesions. Proc. Chin. Acad. Med. Sci. Peking Union Med. Coll. 1990;5:93–96.
    pubmed: 2243839
  28. Shabani F., Farasat A., Mahdavi M., Gheibi N. Calprotectin (S100A8/S100A9): A Key Protein between Inflammation and Cancer. Inflamm. Res. 2018;67:801–812.
    doi: 10.1007/s00011-018-1173-4pubmed: 30083975google scholar: lookup
  29. Jiang Z., Wang X., Li J., Yang H., Lin X. Aldolase A as a Prognostic Factor and Mediator of Progression via Inducing Epithelial–Mesenchymal Transition in Gastric Cancer. J. Cell. Mol. Med. 2018;22:4377–4386.
    doi: 10.1111/jcmm.13732pmc: PMC6111871pubmed: 29992789google scholar: lookup
  30. Gunaletchumy S.P., Seevasant I., Tan M.H., Croft L.J., Mitchell H.M., Goh K.L., Loke M.F., Vadivelu J.. Helicobacter Pylori Genetic Diversity and Gastro-Duodenal Diseases in Malaysia. Sci. Rep. 2014;4:7431.
    doi: 10.1038/srep07431pmc: PMC5377019pubmed: 25503415google scholar: lookup
  31. Contreras-Aguilar M.D., Escribano D., Martínez-Subiela S., Martínez-Miró S., Rubio M., Tvarijonaviciute A., Tecles F., Cerón J.J.. Influence of the Way of Reporting Alpha-Amylase Values in Saliva in Different Naturalistic Situations: A Pilot Study. PLoS ONE 2017;12:e0180100.
  32. Nilsen T., Sunde K., Larsson A. A New Turbidimetric Immunoassay for Serum Calprotectin for Fully Automatized Clinical Analysers. J. Inflamm. 2015;12:45.
    doi: 10.1186/s12950-015-0090-3pmc: PMC4514941pubmed: 26213499google scholar: lookup
  33. Eckersall P.D.. Calibration of Novel Protein Biomarkers for Veterinary Clinical Pathology: A Call for International Action. Front. Vet. Sci. 2019;6:210.
    doi: 10.3389/fvets.2019.00210pmc: PMC6614203pubmed: 31312640google scholar: lookup
  34. Muñoz-Prieto A., Tvarijonaviciute A., Escribano D., Martínez-Subiela S., Cerón J.J.. Use of Heterologous Immunoassays for Quantification of Serum Proteins: The Case of Canine C-Reactive Protein. PLoS ONE 2017;12:e0172188.

Citations

This article has been cited 6 times.
  1. Bishop RC, Arrington JV, Wilkins PA, McCoy AM. Alterations in the Peritoneal Fluid Proteome of Horses with Colic Attributed to Ischemic and Non-Ischemic Intestinal Disease. Animals (Basel) 2025 May 30;15(11).
    doi: 10.3390/ani15111604pubmed: 40509070google scholar: lookup
  2. Botía M, Muñoz-Prieto A, Martínez-Subiela S, Martín-Cuervo M, Hansen S, Manteca X, Cerón JJ, López-Arjona M. Oxytocin in horse saliva: validation of a highly sensitive assay and a pilot report about changes in equine gastric ulcer syndrome. BMC Vet Res 2025 Feb 22;21(1):90.
    doi: 10.1186/s12917-025-04569-3pubmed: 39987089google scholar: lookup
  3. García-Camacho M, Tvarijonaviciute A, Martínez-Subiela S, Cerón JJ, Muñoz-Prieto A. Analytical validation of an automated assay to measure calprotectin (S100A8/A9) in dog saliva and serum and changes in canine leishmaniasis, pyometra and hyperadrenocorticism. BMC Vet Res 2025 Feb 20;21(1):80.
    doi: 10.1186/s12917-024-04443-8pubmed: 39980018google scholar: lookup
  4. Muñoz-Prieto A, Cerón JJ, Tecles F, Cuervo MM, Contreras-Aguilar MD, Ayala I, Oudada-Guillén A, Pardo-Marín L, Hansen S. Measurement of Trace Elements (Zinc, Copper, Magnesium, and Iron) in the Saliva of Horses: Validation Data and Changes in Equine Gastric Ulcer Syndrome (EGUS). Animals (Basel) 2024 Jun 7;14(12).
    doi: 10.3390/ani14121724pubmed: 38929343google scholar: lookup
  5. Muñoz-Prieto A, Llamas-Amor E, Contreras-Aguilar MD, Ayala I, Martín Cuervo M, Cerón JJ, Hansen S. Automated Spectrophotometric Assays for the Measurement of Ammonia and Bicarbonate in Saliva of Horses: Analytical Validation and Changes in Equine Gastric Ulcer Syndrome (EGUS). Metabolites 2024 Feb 28;14(3).
    doi: 10.3390/metabo14030147pubmed: 38535307google scholar: lookup
  6. Cerón JJ, Ortín-Bustillo A, López-Martínez MJ, Martínez-Subiela S, Eckersall PD, Tecles F, Tvarijonaviciute A, Muñoz-Prieto A. S-100 Proteins: Basics and Applications as Biomarkers in Animals with Special Focus on Calgranulins (S100A8, A9, and A12). Biology (Basel) 2023 Jun 19;12(6).
    doi: 10.3390/biology12060881pubmed: 37372165google scholar: lookup